Positive CHMP Opinion For BioMarin's Gene Therapy To Treat Severe Hemophilia A

BioMarin Pharmaceutical Inc. (BMRN) on Friday said it received positive opinion from European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for conditional marketing authorization of its investigational gene therapy, valoctocogene roxaparvovec, for the treatment of adults with severe hemophilia A.

The CHMP based its positive opinion on the totality of data from the valoctocogene roxaparvovec clinical development program, including two-year outcomes from the global GENEr8-1 Phase 3 study, supported by five and four years of follow-up from the 6e13 vg/kg and 4e13 vg/kg dose cohorts respectively, in the ongoing Phase 1/2 dose escalation study, BioMarin said.

The company plans to market the drug under the brand name Roctavian.

Roctavian is the first gene therapy to be recommended for approval in Europe for hemophilia A. A final decision is expected in the third quarter of 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Specialty athletic retailer Foot Locker, Inc. reported Friday a second-quarter net profit that plunged from last year, hurt by a sales decline amid markdowns. Quarterly sales met Street estimates. The company also trimmed it adjusted earnings and sales growth guidance for the full-year 2022. Google's hundreds of employees have signed a petition sent to executives demanding extension of abortion care benefits to contract workers. The workers also called to halt donations given to anti-abortion politicians and to expand travel benefits. The petition, circulated by the Alphabet Workers Union, has been signed by over 650 employees at Google's parent company Alphabet Inc. Apple Inc. has released an emergency security update noting that some of its iPhones, iPads and Macs had certain vulnerabilities. The tech major said the flaws potentially allow full admin access to devices. The models affected by the issue include iPhone 6S and later models, several models of the newer iPads, and Mac computers running macOS Monterey and above. The flaws also affect the iPod Touch
Follow RTT